Agilon Health (AGL) Invested Capital (2020 - 2025)
Agilon Health (AGL) has disclosed Invested Capital for 6 consecutive years, with $161.7 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Invested Capital fell 69.84% year-over-year to $161.7 million, compared with a TTM value of $161.7 million through Dec 2025, down 69.84%, and an annual FY2025 reading of $161.7 million, down 69.84% over the prior year.
- Invested Capital was $161.7 million for Q4 2025 at Agilon Health, down from $315.6 million in the prior quarter.
- Across five years, Invested Capital topped out at $1.2 billion in Q2 2021 and bottomed at -$298.2 million in Q1 2021.
- Average Invested Capital over 5 years is $759.2 million, with a median of $795.8 million recorded in 2023.
- The sharpest move saw Invested Capital surged 564.81% in 2021, then crashed 69.84% in 2025.
- Year by year, Invested Capital stood at $1.1 billion in 2021, then dropped by 4.65% to $1.0 billion in 2022, then crashed by 33.1% to $699.5 million in 2023, then fell by 23.35% to $536.2 million in 2024, then plummeted by 69.84% to $161.7 million in 2025.
- Business Quant data shows Invested Capital for AGL at $161.7 million in Q4 2025, $315.6 million in Q3 2025, and $540.5 million in Q2 2025.